Chemoinformaics analysis of 5-methyl-5-propylnonane
| Molecular Weight | 184.367 | nRot | 8 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 0 |
| Exact Molecular Weight | 184.219 | nRing | 0 |
| Solubility: LogS | -6.312 | nHRing | 0 |
| Solubility: LogP | 6.505 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 40.3802 |
| nHD | 0 | BPOL | 28.0898 |
| QED | 0.488 |
| Synth | 2.38 |
| Natural Product Likeliness | 0.263 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.034 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.429 |
| MDCK | 0.00000993 |
| BBB | 0.331 |
| PPB | 0.975917 |
| VDSS | 2.436 |
| FU | 0.028239 |
| CYP1A2-inh | 0.371 |
| CYP1A2-sub | 0.85 |
| CYP2c19-inh | 0.499 |
| CYP2c19-sub | 0.938 |
| CYP2c9-inh | 0.231 |
| CYP2c9-sub | 0.941 |
| CYP2d6-inh | 0.245 |
| CYP2d6-sub | 0.392 |
| CYP3a4-inh | 0.28 |
| CYP3a4-sub | 0.122 |
| CL | 4.414 |
| T12 | 0.125 |
| hERG | 0.101 |
| Ames | 0.003 |
| ROA | 0.055 |
| SkinSen | 0.42 |
| Carcinogencity | 0.049 |
| EI | 0.923 |
| Respiratory | 0.371 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.588317 |